Dana G. Wolf

10.0k total citations · 2 hit papers
159 papers, 6.6k citations indexed

About

Dana G. Wolf is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Dana G. Wolf has authored 159 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Epidemiology, 53 papers in Infectious Diseases and 42 papers in Immunology. Recurrent topics in Dana G. Wolf's work include Cytomegalovirus and herpesvirus research (58 papers), Herpesvirus Infections and Treatments (25 papers) and SARS-CoV-2 and COVID-19 Research (21 papers). Dana G. Wolf is often cited by papers focused on Cytomegalovirus and herpesvirus research (58 papers), Herpesvirus Infections and Treatments (25 papers) and SARS-CoV-2 and COVID-19 Research (21 papers). Dana G. Wolf collaborates with scholars based in Israel, United States and Germany. Dana G. Wolf's co-authors include Stephen A. Spector, Ofer Mandelboim, Esther Oiknine‐Djian, Mark N. Prichard, Manfred Marschall, Thomas Efferth, Thomas Stamminger, Simcha Yagel, Debra Goldman‐Wohl and Marta R. Romero and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Dana G. Wolf

157 papers receiving 6.4k citations

Hit Papers

Host Immune System Gene Targeting by a Viral miRNA 2007 2026 2013 2019 2007 2008 100 200 300 400 500

Peers

Dana G. Wolf
Jean K. Lim United States
Damien Chaussabel United States
Shu‐Yuan Xiao United States
Randy A. Albrecht United States
Mark T. Heise United States
William T. London United States
Daniel F. Hoft United States
Dana G. Wolf
Citations per year, relative to Dana G. Wolf Dana G. Wolf (= 1×) peers Bruno B. Andrade

Countries citing papers authored by Dana G. Wolf

Since Specialization
Citations

This map shows the geographic impact of Dana G. Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana G. Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana G. Wolf more than expected).

Fields of papers citing papers by Dana G. Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana G. Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana G. Wolf. The network helps show where Dana G. Wolf may publish in the future.

Co-authorship network of co-authors of Dana G. Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Dana G. Wolf. A scholar is included among the top collaborators of Dana G. Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana G. Wolf. Dana G. Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Korem, Maya, Efrat Orenbuch‐Harroch, Matan J. Cohen, et al.. (2025). Risk factors associated with cytomegalovirus reactivation and disease in critically-ill COVID-19 and non-COVID-19 patients, concomitantly admitted to intensive care. Scientific Reports. 15(1). 41840–41840.
2.
Kumar, Awanish, Ofer Shamni, Ayelet Peretz, et al.. (2023). A method for cleaning of used disposable plastic parts from automated RNA extraction system. Polymers for Advanced Technologies. 35(1). 1 indexed citations
3.
Kahlon, Shira, Liat Dassa, Natan Stein, et al.. (2023). CLPTM1L is a GPI-anchoring pathway component targeted by HCMV. The Journal of Cell Biology. 222(9). 2 indexed citations
4.
Cohen, S. M., Michal Lipschuetz, Esther Oiknine‐Djian, et al.. (2023). Boosting maternal and neonatal anti–SARS-CoV-2 humoral immunity using a third mRNA vaccine dose. JCI Insight. 8(1).
5.
Oster, Yonatan, Wiessam Abu Ahmad, Ayelet Michael-Gayego, et al.. (2023). Viral and Bacterial Respiratory Pathogens during the COVID-19 Pandemic in Israel. Microorganisms. 11(1). 166–166. 7 indexed citations
6.
Averbuch, Diana, Eitan Kerem, Malena Cohen‐Cymberknoh, et al.. (2023). Pediatric respiratory admissions and related viral infections during the COVID‐19 pandemic. Pediatric Pulmonology. 58(7). 2076–2084. 8 indexed citations
7.
Solomon, Abraham, et al.. (2022). Occurrence of Herpes Viruses in Morphologically Normal Corneas. Cornea. 42(4). 412–415. 2 indexed citations
8.
Nasereddin, Abedelmajeed, et al.. (2022). Identification of SARS-CoV-2 Variants of Concern Using Amplicon Next-Generation Sequencing. Microbiology Spectrum. 10(4). e0073622–e0073622. 14 indexed citations
9.
Ben‐Dov, Iddo Z., Yonatan Oster, Ashraf Imam, et al.. (2022). Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3–5 months follow-up. Journal of Nephrology. 35(1). 153–164. 17 indexed citations
10.
Bentov, Yaakov, Ofer Beharier, Caryn Greenfield, et al.. (2021). Ovarian follicular function is not altered by SARS–CoV-2 infection or BNT162b2 mRNA COVID-19 vaccination. Human Reproduction. 36(9). 2506–2513. 99 indexed citations
12.
Slavin, Moriya, Keren Zohar, Esther S. Brielle, et al.. (2021). Targeted in situ cross-linking mass spectrometry and integrative modeling reveal the architectures of three proteins from SARS-CoV-2. Proceedings of the National Academy of Sciences. 118(34). 36 indexed citations
13.
Joseph-Strauss, Daphna, Ayelet Rahat, Miriam Adam, et al.. (2021). Early sample tagging and pooling enables simultaneous SARS-CoV-2 detection and variant sequencing. Science Translational Medicine. 13(618). eabj2266–eabj2266. 9 indexed citations
14.
Seidel, Einat, Liat Dassa, Esther Oiknine‐Djian, et al.. (2021). The human cytomegalovirus protein UL147A downregulates the most prevalent MICA allele: MICA*008, to evade NK cell-mediated killing. PLoS Pathogens. 17(5). e1008807–e1008807. 14 indexed citations
15.
Charpak‐Amikam, Yoav, Einat Seidel, Esther Oiknine‐Djian, et al.. (2017). Human cytomegalovirus escapes immune recognition by NK cells through the downregulation of B7-H6 by the viral genes US18 and US20. Scientific Reports. 7(1). 8661–8661. 39 indexed citations
16.
Vitenshtein, Alon, Yiska Weisblum, Anne Halenius, et al.. (2016). CEACAM1-Mediated Inhibition of Virus Production. Cell Reports. 15(11). 2331–2339. 18 indexed citations
17.
Weisblum, Yiska, Amos Panet, Zichria Zakay‐Rones, et al.. (2011). Modeling of Human Cytomegalovirus Maternal-Fetal Transmission in a Novel Decidual Organ Culture. Journal of Virology. 85(24). 13204–13213. 62 indexed citations
18.
Matoth, Israel, et al.. (2007). Steroids for Deteriorating Herpes Simplex Virus Encephalitis. Pediatric Neurology. 37(3). 229–232. 24 indexed citations
19.
Markel, Gal, Dana G. Wolf, Jacob H. Hanna, et al.. (2002). Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions. Journal of Clinical Investigation. 110(7). 943–953. 90 indexed citations
20.
Wolf, Yehuda G., Talia Sasson, Dana G. Wolf, et al.. (1997). Thoracic aorta transobturator bipopliteal bypass as eventual durable reconstruction after removal of an infected aortofemoral graft. Journal of Vascular Surgery. 26(4). 693–696. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026